CMGGF(CMGGF)
CMGGF
No analyst ratings available
No analyst price targets available for CMGGF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $124.81B | $145.57B | $166.06B | $176.79B | $203.21B |
| Low | $122.26B | $132.49B | $156.56B | $166.68B | $191.59B |
| High | $127.79B | $160.05B | $176.66B | $188.08B | $216.18B |
| EBITDA Avg | $29.66B | $34.60B | $39.46B | $42.02B | $48.29B |
| Low | $29.06B | $31.49B | $37.21B | $39.61B | $45.53B |
| High | $30.37B | $38.04B | $41.98B | $44.70B | $51.38B |
| EBIT Avg | $27.34B | $31.89B | $36.38B | $38.73B | $44.52B |
| Low | $26.78B | $29.03B | $34.30B | $36.52B | $41.97B |
| High | $28.00B | $35.06B | $38.70B | $41.20B | $47.36B |
| Net Income Avg | $70.11B | $81.82B | $94.07B | $102.18B | $118.17B |
| Low | $64.90B | $75.74B | $87.07B | $94.58B | $109.39B |
| High | $75.93B | $88.61B | $101.88B | $110.66B | $127.98B |
| EPS Avg | $20.53 | $23.96 | $27.55 | $29.92 | $34.61 |
| Low | $19.01 | $22.18 | $25.50 | $27.70 | $32.03 |
| High | $22.24 | $25.95 | $29.83 | $32.41 | $37.48 |
| Analysts (Rev / EPS) | 6 / 1 | 7 / 1 | 4 / 1 | 3 / 1 | 6 / 1 |
| Metric | Q3 2026 |
|---|---|
| Revenue Avg | $1.71T |
| Low | $1.71T |
| High | $1.71T |
| EBITDA Avg | $405.51B |
| Low | $405.51B |
| High | $405.51B |
| EBIT Avg | $373.81B |
| Low | $373.81B |
| High | $373.81B |
| Net Income Avg | — |
| Low | — |
| High | — |
| EPS Avg | — |
| Low | — |
| High | — |
| Analysts (Rev / EPS) | 1 / — |